In clinical testing and routine clinical use for over 6 years, no implant migration or evidence of granuloma formation has been observed.
Unique mechanism ofaction
Over time the RADIESSE Voice implant carrier gel is resorbed and the Calcium Hydroxylapatite particles support in-growth of new collagen. The durable Calcium Hydroxylapatite microspheres degrade slowly over years for a long -lastingeffect. The implant remains soft after injection and does not ossify. 
Injection techniques
RADIESSE products can be injected through a 25-gauge needle in the operating room or in the office using a trans-thyroid cartilage, trans-cricothyroid membrane or thyrohyoid approach-",
Convenient and easy-to-use
RADiESSE Voice Implant (CaHA + gel carrier) initially performs asa filler.
Macrophages startto degrade gel carrier (2-3 months).
Macrophages dissolve gelcarrier asnew collagen forms.
The RADIESSE Voice injectable implant contains synthetic Calcium Hydroxylapatite (CaHA) microspheres, which have a diameter of 25-45 micron, suspended in an aqueous resorbable carrier gel. The product is injectable through a 25-gauge needle. RADIESSE Voice implant provides vocal fold augmentation with results that typically lasts 1 year. r
RADiESSE Voice Products
The RADIESSE Voice Gel injectable implant contains synthetically derived polymers, with no CaHA microspheres, and it is suitable for short term vocal fold augmentation in patients where reversible nerve damage is suspected, or in patients wishing a short term augmentation before deciding to have a long term augmentation done with the RADIESSE Voice implant. Proven safe -no granuloma formation or major complications have been reported.' Proven long-lasting -results typically last more than 12 months'», 
Clinically proven results

